Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series
Authors:
Open Access
- 10 February 2010
- journal article
- Published by Springer Nature in Cases Journal
- Vol. 3 (1) , 54
Abstract
Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave® device therapy and program.Keywords
This publication has 14 references indexed in Scilit:
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic ratsLife Sciences, 2009
- Does the Proximity of an Amputation, Length of Time Between Foot Ulcer Development and Amputation, or Glycemic Control at the Time of Amputation Affect the Mortality Rate of People with Diabetes who Undergo an Amputation?Advances in Skin & Wound Care, 2008
- Incorporating Wound Healing Strategies to Improve Palliation (Symptom Management) in Patients with Chronic WoundsJournal of Palliative Medicine, 2007
- Understanding eNOS for Pharmacological Modulation of Endothelial Function: A Translational ViewCurrent Pharmaceutical Design, 2007
- Diagnosis and Treatment of Diabetic Foot InfectionsPlastic and Reconstructive Surgery, 2006
- Endostatin Down-Regulates Soluble Guanylate Cyclase (sGC) in Endothelial Cells In Vivo: Influence of Endostatin on Vascular Endothelial Growth Factor (VEGF) SignalingEndothelium, 2005
- A cost analysis of diabetic lower-extremity ulcers.Diabetes Care, 2000
- Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcersThe Journal of Pathology, 2000
- Prospective, Multicenter Study of Managing Lower Extremity Venous UlcersAnnals of Vascular Surgery, 1994